Author

Anne-Marie Beltrand

OpenAlex ID: A5154082863

Efficacy and safety of low-dose IL-2 in people with newly diagnosed type 1 diabetes (DIABIL-2): a double-blind, multicentre, randomised, placebo-controlled, phase 2b trial

2026 · Michelle Rosenzwajg, Agnès Hartemann, et al. · The Lancet Diabetes & Endocrinology · 1

Works count: 1

Citation count: 1

H-index: 1

I10-index: